The FABI Antibody (PACO36870) is a highly specific and sensitive tool for researchers studying CD300A, a key immune regulatory molecule. This polyclonal antibody, generated in rabbits, boasts high reactivity with human samples and has been verified for use in Western blot applications. By binding to the CD300A protein, this antibody facilitates precise detection and analysis in a variety of cell types, making it a valuable asset for investigations in immunology and cancer research.CD300A, also recognized as an immune inhibitory receptor, plays a pivotal role in maintaining immune balance by regulating inflammation and suppressing allergic responses.
Its pivotal role in immune response modulation positions it as a promising target for further exploration in diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions. Unmasking the functions of CD300A is essential in the quest to develop novel therapies that either amplify or curb immune activity in these disease states.
Antibody Name:
fabI Antibody (PACO36870)
Antibody SKU:
PACO36870
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:2000-1:10000, WB:1:1000-1:5000
Species Reactivity:
Staphylococcus aureus, Mouse
Immunogen:
Recombinant Staphylococcus aureus Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI protein (1-256AA)
Western blot. All lanes: fabI antibody at 5µg/ml + Mouse heart tissue. Secondary. Goat polyclonal to rabbit IgG at 1/10000 dilution. Predicted band size: 28 kDa. Observed band size: 28 kDa.
Background:
Catalyzes the reduction of a carbon-carbon double bond in an enoyl moiety that is covalently linked to an acyl carrier protein (ACP). Involved in the elongation cycle of fatty acid, which are used in the lipid metabolism.
Catalyzes the reduction of a carbon-carbon double bond in an enoyl moiety that is covalently linked to an acyl carrier protein (ACP). Involved in the elongation cycle of fatty acid which are used in the lipid metabolism ().
